These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Drugs which modulate nitric oxide homeostasis are likely to provide therapeutic benefit in cardiovascular disease. Thiemermann C Cardiovasc Res; 1993 Dec; 27(12):2104. PubMed ID: 8313413 [No Abstract] [Full Text] [Related]
8. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Nava E; Palmer RM; Moncada S Lancet; 1991 Dec 21-28; 338(8782-8783):1555-7. PubMed ID: 1683974 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide as a target for therapy in septic shock. Cobb JP; Cunnion RE; Danner RL Crit Care Med; 1993 Sep; 21(9):1261-3. PubMed ID: 8370286 [No Abstract] [Full Text] [Related]
10. Overproduction of nitric oxide in cytokine-mediated and septic shock. Kilbourn RG; Griffith OW J Natl Cancer Inst; 1992 Jun; 84(11):827-31. PubMed ID: 1375655 [No Abstract] [Full Text] [Related]
11. Nitric oxide in the clinical arena. Lancet; 1991 Dec 21-28; 338(8782-8783):1560-2. PubMed ID: 1683976 [No Abstract] [Full Text] [Related]
12. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Wolfe TA; Dasta JF Ann Pharmacother; 1995 Jan; 29(1):36-46. PubMed ID: 7536056 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide mediates the vascular actions of cytokines in septic shock. Smith RE; Radomski MW; Moncada S Eur J Clin Invest; 1992 Jun; 22(6):438-9. PubMed ID: 1378789 [No Abstract] [Full Text] [Related]
14. The role of nitric oxide in endotoxin-elicited hypodynamic circulatory failure. Brackett DJ; Lerner MR; Wilson MF Adv Exp Med Biol; 1994; 366():412-3. PubMed ID: 7771273 [No Abstract] [Full Text] [Related]
15. Reversal of refractory hypotension in septic shock by inhibitor of nitric oxide synthase. Lin PJ; Chang CH; Chang JP Chest; 1994 Aug; 106(2):626-9. PubMed ID: 7539733 [TBL] [Abstract][Full Text] [Related]
16. Enhanced basal nitric oxide production in heart failure. Calver A Lancet; 1994 Sep; 344(8926):887-8. PubMed ID: 7916419 [No Abstract] [Full Text] [Related]
17. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259 [TBL] [Abstract][Full Text] [Related]
18. Vascular biology: relevance of nitric oxide in vascular and nonvascular tissue with normal and decreased renal function. Blantz RC Blood Purif; 1994; 12(1):30-5. PubMed ID: 7527221 [TBL] [Abstract][Full Text] [Related]
19. Role of nitric oxide in the vascular dysfunction of septic shock. Rees DD Biochem Soc Trans; 1995 Nov; 23(4):1025-9. PubMed ID: 8654674 [No Abstract] [Full Text] [Related]
20. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Kilbourn RG; Cromeens DM; Chelly FD; Griffith OW Crit Care Med; 1994 Nov; 22(11):1835-40. PubMed ID: 7956289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]